Drug Name: Lamivudine Tablets

Approval number: 0.1g×7 Tablets；国药准字J20130114

                       0.1g×14Tablets；国药准字J20130114

Description: Gray diamond film-coated tablets, engraved with "GXEJ7" in one side of the body.

Indication: Treatment of the adult chronic hepatitis b patients associated with elevated alanine aminotransferase and virus activity copy, liver function of compensatory.